MiMedx (NSDQ:MDXG) said today that it it named Timothy Wright as its new chief exec, effective May 13. Wright will replace David Coles, who has served as the interim CEO since last July, the Marietta, Ga.-based company said. MiMedx said that Wright has more than 30 years of experience in pharma, medtech and biotech. Prior to […]
Qualcomm (NASDAQ:QCOM) medical-device focused subsidiary Qualcomm Life has been sold to private equity firm Francisco Partners and renamed to Capsule Tech, as it will now function as a stand-alone business, the PE firm said yesterday. The companies did not reveal any financial details about the transaction, but said that Capsule Tech will continue to operate […]
Wright Medical COO, ex-Tornier CEO Mowry, steps down Wright Medical (NSDQ:WMGI) said yesterday its exec veep and chief operating officer, and former Tornier (NSDQ:TRNX) CEO, David Mowry will be stepping down from the company on May 6 to pursue other opportunities. The company did not indicate who would take Mowry’s position. Read more
Qualcomm (NASDAQ: QCOM) medical data management subsidiary Capsule Tech said it received FDA 510(k) clearance for its SmartLinx Vitals Plus patient monitoring system. The SmartLinx system integrates remote monitoring of patient vital signs and clinical patient documentation into a single platform as part of Capsule’s broader SmartLinx medical device information system. “Today’s patient bedside is crowded with […]
Updated with comments from Qualcomm and Capsule Tech Qualcomm (NASDAQ: QCOM) said yesterday its subsidiary Qualcomm Life has purchased medical data management company Capsule Tech for an undisclosed amount. The San Diego, Calif.-based company said the acquisition will allow Qualcomm Life to expand from into hospitals, taking over Capsule’s 1,930 hospital clients in 38 countries. “For Qualcomm […]
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this Halloween, make sure you’re still in the know with MassDevice +3.
Former Boston Scientific Corp. (NYSE:BSX) CEO James Tobin joined the board of directors at Aptus Endosystems Inc., a device company specializing in treating abdominal aortic aneurysms.
Tobin made quite a name for himself while occupying the corner office at med-tech giant Boston Scientific, where he was chief for a decade. He officially retired in July 2009 and was succeeded by Ray Elliott.